TGFB2, Human (Lerdelimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-TGFB2, Human (Lerdelimumab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | TGFB2, Human (Lerdelimumab biosimilar) |
| Clone | Lerdelimumab |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | IgG4 |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | n/a |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-Human TGFB2 Recombinant Antibody. Lerdelimumab (CAT-152, intended trade name Trabio) is a human monoclonal antibody and an immunosuppressive drug targeting TGF beta 2. It was being developed to reduce scarring after glaucoma drainage surgery. Development was stopped in late 2005 after unsuccessful trial results for that condition. |
| Immunogen | n/a |
| Other Names | Anti-TGFB2 Recombinant Antibody, Research Grade Lerdelimumab, Anti-Human TGFB2 Recombinant Antibody, CAT-152, Trabio, Antibody Drug Analogues, Monoclonal Antibody, YR1117, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | CAS: 285985-06-0 |
| Catalog # | YR1117 |
| Price | please inquire |
| Order / More Info | TGFB2, Human (Lerdelimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.